phase readout
saveNCT07447570: Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE2. Conditions: Head and Neck Cancer, Radiotherapy, Anti-PD-1/CTLA-4 Antibody
view source ↗
comments(0)
5-min edit window · permanent after that